Researchers in recent studies have pointed out that numerous signaling pathways, including the epidermal growth factor receptor, HER2, IGFR and BRCA1/2 pathways [3,36,37], could contribute to the malignancy of ER- breast cancer. This evidence concerns the gene IGF1R and breast cancer.